Cargando…

Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France

BACKGROUND: The excess mortality observed in Acute Myeloblastic Leukaemia (AML) patients, partly attributed to unequal access to curative treatments, could be linked to care pathways. METHODS: We included 1039 AML incident cases diagnosed between 2012–2016 from the 3 French blood cancer registries (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atsou, Kueshivi Midodji, Rachet, Bernard, Cornet, Edouard, Chretien, Marie‐Lorraine, Rossi, Cédric, Remontet, Laurent, Roche, Laurent, Giorgi, Roch, Gauthier, Sophie, Girard, Stéphanie, Böckle, Johann, Wasse, Stéphane Kroudia, Rachou, Helene, Bouzid, Laila, Poncet, Jean‐Marc, Orazio, Sébastien, Monnereau, Alain, Troussard, Xavier, Mounier, Morgane, Maynadie, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134294/ https://www.ncbi.nlm.nih.gov/pubmed/36710405 http://dx.doi.org/10.1002/cam4.5645

Ejemplares similares

PB1855: USE OF MACHINE LEARNING MODEL TO IDENTIFY PATIENTS RECEIVING OPTIMAL TREATMENT AND THE ASSOCIATED NON-BIOLOGICAL FACTORS: A POPULATION-BASED STUDY
por: Atsou, Kueshivi Midodji, et al.
Publicado: (2023)

Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study
por: Wasse, Stephane Kroudia, et al.
Publicado: (2023)

P1746: LONG-TERM NON-HODGKIN LYMPHOMA SURVIVORS IN CÔTE D’OR: HEALTH-RELATED QUALITY OF LIFE AND LIVING CONDITIONS.
por: Wasse, S., et al.
Publicado: (2022)

Second‐ or third‐generation tyrosine kinase inhibitors in first‐line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
por: Canet, Jim, et al.
Publicado: (2021)

Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
por: Le Guyader-Peyrou, Sandra, et al.
Publicado: (2017)

Analysis of medico-social factors for return to work among patients presenting with haematological malignancy (adamantine): results of a ‘pilot study’
por: Clin, Bénédicte, et al.
Publicado: (2020)

Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia
por: Cornet, Edouard, et al.
Publicado: (2014)

Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database
por: Cottin, Yves, et al.
Publicado: (2022)

Granulocyte function in myeloblastic leukaemia.
por: Wilkinson, P. M., et al.
Publicado: (1975)

STUDIES ON THE MATURATION OF MYELOBLASTS INTO MYELOCYTES AND ON AMITOTIC CELL DIVISION IN THE PERIPHERAL BLOOD IN SUBACUTE MYELOBLASTIC LEUCEMIA
por: Sabin, F. R., et al.
Publicado: (1924)

“The Early Specialised Bird Catches the Worm!” – A Specialised Sampling Model in the Development of Football Talents
por: Sieghartsleitner, Roland, et al.
Publicado: (2018)

Adiponectin in relation to childhood myeloblastic leukaemia
por: Petridou, E, et al.
Publicado: (2006)

A Case of Acute Myeloblastic Leukæmia
por: Fleming, Robert A., et al.
Publicado: (1924)

Cytomegalovirus keratitis in acute myeloblastic leukemia
por: Daryabari, Seyed-Hashem, et al.
Publicado: (2023)

P938: SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA IN THE GENERAL POPULATION BASED ON DATA FROM TWO FRENCH CANCER REGISTRIES
por: Hulin, Cyrille, et al.
Publicado: (2023)

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
por: Taylor, G. M., et al.
Publicado: (1976)

Describing the association between socioeconomic inequalities and cancer survival: methodological guidelines and illustration with population-based data
por: Belot, Aurélien, et al.
Publicado: (2018)

Assessment of Drug Sensitivity of Human Leukaemic Myeloblasts: I. Labelling Human Myeloblasts with (125)IUdR for Survival Studies in Mice
por: FalcãO, R. P., et al.
Publicado: (1977)

PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL
por: Wasse, Stephane, et al.
Publicado: (2023)

Hairy cell leukemia 2018: Update on diagnosis, risk‐stratification, and treatment
por: Troussard, Xavier, et al.
Publicado: (2017)

Proceedings: Surface immunological markers in acute myeloblastic leukaemia.
por: Taylor, G. M., et al.
Publicado: (1975)

Expression of the p53 oncogene in acute myeloblastic leukemia
Publicado: (1986)

Actual biological diagnosis of acute myeloblastic leukemia in children
por: Buga Corbu, V, et al.
Publicado: (2014)

Medullary allotransplant in acute myeloblastic leukemia in a child
por: Buga Corbu, V, et al.
Publicado: (2014)

Label-free detection of leukemic myeloblasts in hyaluronic acid
por: Park, Suhyun, et al.
Publicado: (2022)

Factors hindering health care delivery in nomadic communities: a cross-sectional study in Timbuktu, Mali
por: Sangare, Moussa, et al.
Publicado: (2021)

Is the Social Gradient in Net Survival Observed in France the Result of Inequalities in Cancer-Specific Mortality or Inequalities in General Mortality?
por: Tron, Laure, et al.
Publicado: (2023)

Management of suspected monogenic lung fibrosis in a specialised centre
por: Borie, Raphael, et al.
Publicado: (2017)

Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
por: Sonis, S. T., et al.
Publicado: (1977)

T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia
Publicado: (1986)

Acute acalculous cholecystitis complicating chemotherapy for acute myeloblastic leukemia
por: Kassar, Olfa, et al.
Publicado: (2015)

Specialisation among Hospitals
Publicado: (1909)

Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM
por: Mounier, Morgane, et al.
Publicado: (2021)

Comparing outcomes of ILD patients managed in specialised versus non-specialised centres
por: Marijic, Pavo, et al.
Publicado: (2022)

The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
por: Holmes, J. A., et al.
Publicado: (1994)

HISTOCHEMISTRY OF THE CENTRIOLES AND CENTROSOMES OF THE LEUKEMIC CELLS FROM HUMAN MYELOBLASTIC LEUKEMIA
por: Ackerman, G. Adolph
Publicado: (1961)

Pseudo Chediak Higashi-like inclusions in myeloblasts in AML-M2
por: Sharma, Sunita, et al.
Publicado: (2013)

The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia
por: Wang, Xiao-Shuang, et al.
Publicado: (2008)

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
por: Chen, Yu-Jen, et al.
Publicado: (2016)

Performance evaluation and relevance of the CellaVision™ DM96 system in routine analysis and in patients with malignant hematological diseases
por: CORNET, E, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hpvd2rrv4evjl5ngo2en9p7dea